Upcoming Webinars & Online Events

This webinar will explore the landscape of organoid research, highlighting the latest technological advances, such as AI and automation, that are shaping the field.

In this webinar, our expert speaker will share insights on optimizing PCR performance for applications within cell and gene therapy development, including biodistribution, transgene expression, viral shedding and cellular kinetics.

This online event will highlight the latest technologies in food and beverage analysis with a focus on food quality assurance and combating food fraud, ensuring that consumers have access to safe, authentic and high-quality food products.

In this webinar, we’ll explore the latest innovations in antibody screening, including next-generation screening, high-throughput platforms and machine learning tools that are accelerating the pace of discovery and development.

This webinar explores how the long, real-time reads delivered by Oxford Nanopore sequencing can resolve challenging genomic regions and detect base modifications in a single data set, providing access to previously hidden variation in rare and comple

This webinar will explore the recent advancements in chromatography solutions and the latest strategies for optimizing the purification of bispecific antibodies, from initial capture to final polishing steps.

This webinar features two expert speakers who will share insights into the latest LC methods and technologies.

New for 2025, this event will cover the innovative technologies driving this field, including next-generation sequencing, liquid biopsy, AI-driven diagnostic tools and their integration into clinical practice to transform patient outcomes.

In this webinar, Dr. Theo Roth will discuss how CRISPR-All can be used to push human genetics beyond their evolved functionality, enabling researchers to engineer synthetic cell states with therapeutic potential.

The drug discovery landscape is rapidly evolving with the integration of new technologies and methodologies. Returning for 2025, this event will focus on small molecule and biologic drug development, high-throughput screening and novel drug targets.